Africa produces less than 1% of the human vaccines it uses. To effectively respond in time of outbreaks and pandemics, Africa must expand its vaccine development and production capabilities to cater for its growing population. Successfully establishing such an industry at scale is a multifaceted endeavour to create an enabling environment. This article highlights key factors and considerations for establishing local vaccine manufacturing.
B.1.1.7 variant associated with higher mortality
Latest NewsThe B.1.1.7 variant of SARS-CoV-2, which was first identified in the UK, may be associated with an increased risk of death, a Nature study suggests.
Roche in take-over deal with GenMark Diagnostics
Latest NewsRoche to acquire GenMark Diagnostics, Inc., to access platform to test for broad range of pathogens with one patient sample.
Media hype on Denmark’s decision to halt AZD1222 vaccination
Latest NewsWhile media reports suggest AstraZeneca’s COVID-19 jab might have caused blot clots, the EMA didn’t confirm a causal relationship.
Roche Phase III study misses COVID-19 endpoint
Latest NewsVaccine production in Africa: an urgent priority
BackgroundAfrica produces less than 1% of the human vaccines it uses. To effectively respond in time of outbreaks and pandemics, Africa must expand its vaccine development and production capabilities to cater for its growing population. Successfully establishing such an industry at scale is a multifaceted endeavour to create an enabling environment. This article highlights key factors and considerations for establishing local vaccine manufacturing.
A very “cool” topic in the parmaceutical industry
Sponsored PublicationsThe current debates regarding vaccine production and logistics have also made it clear even to the layman: Pharmaceutical production depends on cold. Temperatures below -80?°C are just as common as the requirement to freeze precursors such as blood plasma within a specified time period. Refrigeration specialists with pharmaceutical know-how are in demand for these challenging tasks.
New CSO at Toxys B.V.
AppointmentsTorben Osterlund is the new Chief Scientific Officer of the Dutch biotech company Toxys B.V., based in Leiden
BioPhero A/S raises US$17m in Series A funding
Latest NewsDanish sustainable crop protection company, BioPhero AS, has raised $17m in Series A funding led by DCVC Bio.
PCR-test reveals risk of genotoxity of genome editing
Latest NewsGerman researchers have presented a new method to assess on-target and off-target effects of CRISPR-Cas nucleases or TALENs.
EMA starts rolling review for Sputnik V vaccine
Latest NewsEMA’s human medicines committee has started a rolling review of Sputnik V, a COVID-19 vaccine developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology.